INC Research Holdings ROE 2012-2018 | SYNH

Current and historical return on equity (ROE) values for INC Research Holdings (SYNH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. INC Research Holdings ROE for the three months ending September 30, 2018 was 8.67%.
INC Research Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $-0.04B $2.83B -1.24%
2018-06-30 $-0.17B $2.82B -5.91%
2018-03-31 $-0.19B $2.91B -7.95%
2017-12-31 $-0.14B $3.02B -8.25%
2017-09-30 $-0.09B $3.03B -8.67%
2017-06-30 $0.09B $0.35B 28.14%
2017-03-31 $0.12B $0.34B 38.75%
2016-12-31 $0.11B $0.30B 40.22%
2016-09-30 $0.11B $0.26B 41.18%
2016-06-30 $0.12B $0.29B 43.12%
2016-03-31 $0.11B $0.25B 40.86%
2015-12-31 $0.12B $0.22B 38.24%
2015-09-30 $0.03B $0.32B 9.44%
2015-06-30 $0.01B $0.28B 2.04%
2015-03-31 $-0.00B $0.41B -0.37%
2014-12-31 $-0.03B $0.39B -16.35%
2014-09-30 $0.03B $0.29B 34.13%
2014-06-30 $0.01B $0.00B inf%
2014-03-31 $-0.00B $0.00B -2.52%
2013-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Services $4.953B $2.672B
INC Research Holdings, Inc. is a global contract research organization. It provides the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Its services include clinical trial management services comprising patient recruitment and retention, project management, clinical monitoring, drug safety/pharmacovigilance, medical affairs, quality assurance, regulatory and medical writing, and functional service; and data services consisting of clinical data management, electronic data capture, and biostatistics. INC Research Holdings, Inc. is headquartered in Raleigh, North Carolina.
Stock Name Country Market Cap PE Ratio
Express Scripts Holding (ESRX) United States $54.046B 11.17
ICON (ICLR) Ireland $7.551B 23.67
PRA Health Sciences (PRAH) United States $6.697B 27.34
Charles River Laboratories (CRL) United States $6.198B 21.73
Premier (PINC) United States $5.109B 17.34
HealthEquity (HQY) United States $4.266B 83.39
Teladoc (TDOC) United States $3.744B 0.00
NovoCure (NVCR) Jersey $3.128B 0.00
AMN Healthcare Services Inc (AMN) United States $2.800B 19.21
BioTelemetry (BEAT) United States $2.174B 38.41
Medpace Holdings (MEDP) United States $2.055B 25.42
Healthways (TVTY) United States $1.635B 20.10
Intrexon (XON) United States $1.243B 0.00
IKang Healthcare (KANG) China $1.233B 61.21
Natera (NTRA) United States $1.049B 0.00
CareDx (CDNA) United States $1.038B 0.00
China Cord Blood (CO) China $0.729B 20.00
Surgery Partners (SGRY) United States $0.635B 0.00
Apollo Medical Holdings (AMEH) United States $0.605B 0.00
Establishment Labs Holdings (ESTA) $0.542B 0.00
Civitas Solutions (CIVI) United States $0.495B 9.75
Interpace Diagnostics (IDXG) United States $0.029B 0.00
OpGen (OPGN) United States $0.009B 0.00
Cancer Genetics (CGIX) United States $0.006B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.002B 0.00